Edward M Basile sold $540K of TransMedics (TMDX)

Executed Oct 29 2025, disclosed Oct 31 2025, 2 days later.

Value, as filed

$540K

4,142 sh × $130.45

Executed

Oct 29 2025

the trade date, as filed

Disclosed

Oct 31 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EB Edward M Basile Director profile →

Edward M Basile (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in TransMedics Group, Inc. (TMDX). The largest single filing was $540K of TMDX (4,142 sh × $130.45, as filed), executed Oct 29 2025.

The name

TMDX TransMedics Group, Inc. TMDX · Healthcare · 21 filings in 24 months ticker →

Healthcare · TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage orga…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Edward M Basile in TMDX

TMDXSALE TransMedics Group, Inc. $520K
4,143 sh × $125.51
Exec Aug 4 2025
Filed Aug 5 2025 · 5:30 PM ET TMDXSALE TransMedics Group, Inc. $632K
5,000 sh × $126.45
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET TMDXSALE TransMedics Group, Inc. $694K
6,000 sh × $115.63
Exec May 9 2025
Filed May 13 2025 · 5:30 PM ET TMDXSALE TransMedics Group, Inc. $564K
6,750 sh across 2 lots
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET